Charite Universitaetsmedizin Berlin KöR — Sponsor Intelligence | 26 EU Trials

Filter these 26 trials by condition, phase, country and more.

Open in Search →

26 Registered trials

10 Recruiting

10 Completed trials

15 Countries active

71 Unique IMPs

100% Results reported

Phase III

Phase II

Phase I/II

Phase IV

Phase III: 5 Phase II: 9 Phase I/II: 7 Phase IV: 4 Phase I (Other): 1

Oversight events:

1 serious breach 2 temporary halts 1 corrective measure across 3 trials

View oversight register →

100%

10 of 10 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Rheumatoid arthritis 2 Acute respiratory distress syndrome 1 Microscopic polyangiitis 1 Head and neck cancer metastatic 1 Granulomatosis with polyangiitis 1 Axial spondyloarthritis 1 Psoriasis 1

Top IMPs

DEUCRAVACITINIB 3 KYV-101 2 METHOTREXATE 2 METHYLPREDNISOLONE 2 MITOXANTRONE 2 PARACETAMOL 2 PEGASPARGASE 2 TACROLIMUS 2 TREG02 2 VINCRISTINE SULFATE 2 ABATACEPT 1 AMPHOTERICIN B 1

All trials

26 total

A phase I/IIa, prospective, mono-center, double-blinded, randomized, controlled study to assess the safety and efficacy of applying PLX-PAD … Not authorised

2023-504212-15-00 Phase I/II 1 country CETIRIZINE DIHYDROCHLORIDE; EMIPLACEL
IntReALL BCP 2020 – International Study for Treatment of Childhood Relapsed Precursor B-cell ALL 2020 Pending

2023-509392-17-00 Phase III 11 countries BLINATUMOMAB; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN HYDROCHLORIDE; DEXAMETH…
Anti-CD 19 CAR-T cell therapy in patients with ANCA Vasculitis - the IDEAL trial Pending

2024-517303-36-00 Phase I/II 1 country CYCLOPHOSPHAMIDE MONOHYDRATE; FLUDARABINE PHOSPHATE; KYV-101
Dehydroepiandrosterone (DHEA) as augmentation of standard antidepressants in treatment-resistant depression: a randomized controlled trial (… Pending

2024-517963-21-00 Phase III 1 country LACTOSE MONOHYDRATE; PRASTERONE
Use of the chemotherapy FOLFIRI and cetuximab if given with treatment breaks or continuously in patients with newly diagnosed metastatic col… Pending

2025-522377-12-00 Phase III 1 country
A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of 250 mg lebrikizumab in patients with localized s… Pending

2025-524435-39-00 Phase II 1 country LEBRIKIZUMAB
A phase I, prospective, mono-center, double-blinded, randomized, controlled study to assess the safety and tolerability of intraarticular in… Recruiting

2024-517421-12-00 Phase I (Other) 1 country
A Phase II Randomized Clinical Trial Comparing Two Cycles Versus Four Cycles of Combination Therapy with Cetuximab, Avelumab, Cisplatin, and… Recruiting

2025-521738-27-00 Phase II 1 country AVELUMAB; CETUXIMAB
A clinical trial applying Regulatory T cells in liver transplant recipients to investigate the safety and tolerability when stopping standar… Recruiting

2023-508261-32-00 Phase I/II 1 country PARACETAMOL; TACROLIMUS; TREG02
Pre-Operative Treatment in rEseCTable cOlon canceR (PROTECTOR/FIRE-10; AIO-KRK-0620; IAG-VO-0323) Prospective, randomized, open-label, multi… Recruiting

2023-508076-11-00 Phase III 1 country
Reduction of plasma cells as an approach to reset autoimmunity in rheumatoid arthritis Recruiting

2024-511536-27-00 Phase I/II 1 country ABATACEPT; DARATUMUMAB
COMparison of B-cell dePletion by rituximAb and anti-CD 19 CAR-T therapy in patients with rhEumatoid arthritis- The COMPARE TRIAL Recruiting

2024-514955-13-00 Phase I/II 1 country KYV-101; RITUXIMAB
A clinical trial applying Regulatory T cells in kidney transplant recipients to investigate the safety and tolerability as an adjunctive the… Recruiting

2024-514398-23-00 Phase I/II 1 country AMPHOTERICIN B; ANTI-T LYMPHOCYTE IMMUNOGLOBULIN FOR HUMAN USE, RABBIT; METHYLPR…
Imlifidase in ANCA-associated Vasculitis Recruiting

2024-516727-13-00 Phase II 1 country IMLIFIDASE
Post-resection/ ablation chemotherapy in patients with metastatic colorectal cancer (FIRE-9 - PORT / AIO-KRK-0418). Prospective, randomized,… Recruiting

2024-512174-10-00 Phase III 1 country
Prospective, randomized, open, multicenter Phase II trial to investigate the efficacy of trifluridine/tipiracil plus panitumumab versus trif… Recruiting

2024-513723-16-00 Phase II 1 country PANITUMUMAB; TRIFLURIDINE, TIPIRACIL HYDROCHLORIDE
ANTELOPE – Atezolizumab/Carboplatin/nab-Paclitaxel vs. Pembrolizumab/Platinum/Pemetrexed in metastatic TTF-1 negative lung adenocarcinoma Ended

2023-505054-17-00 Phase IV 1 country
International Study for Treatment of High Risk Childhood Relapsed ALL 2010 - A randomized Phase II Study Conducted by the Resistant Disease … Ended

2024-513070-21-00 Phase II 11 countries BORTEZOMIB; DEXAMETHASONE; METHOTREXATE; MITOXANTRONE; PEGASPARGASE; VINCRISTINE…
A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety deucravacitinib in patients with chronic hand eczem… Ended

2023-504298-19-00 Phase II 1 country DEUCRAVACITINIB
Phase 2a, double-blind, randomized, placebo-controlled trial of methylprednisolone versus placebo in patients with cognitive deficits in pos… Ended

2023-504826-21-00 Phase II 1 country METHYLPREDNISOLONE; PLACEBO
Tofacitinib in early active axial spondyloarthritis: a prospective, randomized, double-blind, placebo-controlled multicentre study - FASTLAN… Ended

2023-505050-18-00 Phase IV 4 countries NAPROXEN; TOFACITINIB
A study to investigate improvement in physical function in SF-36 with Vericiguat compared with Placebo in participants with post-COVID-19 sy… Ended

2024-517713-33-00 Phase II 1 country VERICIGUAT
A clinical trial investigating Iloprost as medication to improve bone healing in patients with upper arm bone fracture. Ended

2024-512468-71-00 Phase I/II 1 country ILOPROST TROMETAMOL
Treating Nightmares in Posttraumatic Stress Disorder with the α-adrenergic Agents Clonidine and Doxazosin: A Randomized-Controlled Feasibili… Ended

2024-517537-40-00 Phase II 1 country CLONIDINE HYDROCHLORIDE; DOXAZOSIN; DOXAZOSIN MESILATE

Showing 1–24 of 26 trials

← All sponsors A–Z